The two most commonly recommended biological classes of targeted agents include vascular endothelial growth factor (VEGF) antibodies that inhibit cancer angiogenesis and epidermal growth factor receptor (EGFR) inhibitors that block cancer proliferation [4]. The gene discussed is EGFR; the disease is cancer.